111, Inc. (NASDAQ:YI)

Current Assets	2.65 B
Cash & Short-Term Investments	462 M
Receivables	631 M
Other Current Assets	1.56 B
Non-Current Assets	138 M
Long-Term Investments	0
PP&E	122 M
Other Non-Current Assets	16.1 M

Current Liabilities	2.34 B
Accounts Payable	1.72 B
Short-Term Debt	201 M
Other Current Liabilities	420 M
Non-Current Liabilities	64.4 M
Long-Term Debt	55.4 M
Other Non-Current Liabilities	8.96 M

EFFICIENCY

Earnings Waterfall 111, Inc.

Revenue	14.4 B
Cost Of Revenue	13.6 B
Gross Profit	829 M
Operating Expenses	827 M
Operating Income	2.11 M
Other Expenses	22.9 M
Net Income	-20.8 M

RATIOS

0.01% OPERATING MARGIN

FREE CASH FLOW ANALYSIS

Free Cash Flow Analysis 111, Inc.

Net Income	-20.8 M
Depreciation & Amortization	17 M
Capital Expenditures	-15.2 M
Stock-Based Compensation	20.1 M
Change in Working Capital	193 M
Others	-36.1 M
Free Cash Flow	248 M

3. WALL STREET ANALYSTS ESTIMATES

Wall Street Analysts Price Targets 111, Inc.

YI has no price targets from Wall Street.

4. DIVIDEND ANALYSIS

YI does not distribute dividends.

5. COMPETITION

Yunji Inc. operates a social e-commerce platform in the People's Republic of China. It offers a range of product categories that cater various daily needs of users and their households, including beauty and personal care, household goods, cloths, food and fresh produce, computer and electronics, apparel, bags and cases, baby and maternity products, and home appliances.

-8.33 K USD

Overvalued 447904.89%

High Tide Inc. engages in the cannabis retail business in Canada, Europe, the United States, and internationally. The company designs, manufactures, and distributes smoking accessories and cannabis lifestyle products.

11.1 USD

HITI

Undervalued 377.50%

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.

3.21 USD

PETS

Overvalued 2.43%

Aurora Mobile Limited, through its subsidiaries, operates as a mobile app developer service provider in China. The company provides push notification, instant messaging, analytics, sharing and short message service, one-click verification, and other services.

35.9 USD

Undervalued 217.97%

-8.33 K USD

Overvalued 447904.89%

6. Ownership

Insider Ownership 111, Inc.

Summary
Transactions

Sold

0-3 MONTHS

0 USD 0

3-6 MONTHS

0 USD 0

6-9 MONTHS

0 USD 0

9-12 MONTHS

0 USD 0

Bought

0 USD 0

0-3 MONTHS

0 USD 0

3-6 MONTHS

0 USD 0

6-9 MONTHS

0 USD 0

9-12 MONTHS

Date	Value	Insider	Amount	Avg Price
No data available in table

7. News

111, Inc. Announces First Quarter 2025 Unaudited Financial Results Maintained Quarterly Operational Profitability Operating Expenses as a Percentage of Revenues Decreased 30 Basis Points YoY Maintained Quarterly Positive Operating Cash Flow SHANGHAI , June 19, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Net revenues were RMB3.5 billion (US$486.3 million), remaining relatively flat compared to the same quarter last year. prnewswire.com - 4 weeks ago

111, Inc. (YI) Q4 2024 Earnings Call Transcript 111, Inc. (NASDAQ:YI ) Q4 2024 Earnings Conference Call March 20, 2025 7:30 AM ET Company Participants Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Haihui Wang - Chief Operating Officer Conference Call Participants Robert Sassoon - Water Tower Research Shifan Sun - CICC Zoe Bian - Citi Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr. seekingalpha.com - 3 months ago

111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results Achieved First-Ever Annual Operating Profit Bottom Line Improved by RMB332.7 Million YoY in 2024 Operating Expenses as a Percentage of Revenues Decreased 230 Basis Points YoY in 2024 Q4'24 Operating Expenses as a Percentage of Revenues Decreased 470 Basis Points YoY Achieved First-Ever Annual Positive Operating Cash Flow SHANGHAI , March 20, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Net revenues were RMB3.8 billion (US$527.1 million) and gross segment profit (1) was RMB202.5 million (US$27.7 million). prnewswire.com - 3 months ago

111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025 SHANGHAI , March 12, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research ("WTR") on Wednesday, March 26, 2025 at 11:00 a.m. ET. Mr. Junling Liu, Co-Founder, Chairman, and Chief Executive Officer of 111, will discuss the Company's Q4 2024 earnings (to be reported on Thursday, March 20, 2024), its priorities and goals for 2025, and an updated overview of the macroenvironment. prnewswire.com - 4 months ago

111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow SHANGHAI , Feb. 20, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2024 ended December 31, 2024, before the U.S. market opens on Thursday, March 20, 2025. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 20, 2025 (7:30 PM Beijing Time on the same day). prnewswire.com - 4 months ago

111, Inc. Regains Compliance with NASDAQ Requirement SHANGHAI , Feb. 11, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, announced today that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") on February 10, 2025, confirming that Nasdaq has determined that for the last ten consecutive business days, from January 24, 2025 to February 7, 2025, the closing bid price of the Company's American Depositary Shares has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5450(a)(1). prnewswire.com - 5 months ago

Compound Semiconductor Market to surpass USD 111.6 billion by 2032, Says Global Market Insights inc. Compound Semiconductor Industry size is expected to register 10.9% CAGR between 2024 and 2032 propelled by electric vehicles and renewable energy. Compound Semiconductor Industry size is expected to register 10.9% CAGR between 2024 and 2032 propelled by electric vehicles and renewable energy. globenewswire.com - 5 months ago

111, Inc. Announces ADS Ratio Change SHANGHAI , Jan. 8, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it plans to change the ratio of its American Depositary Shares ("ADSs") to Class A ordinary shares from one (1) ADS representing two (2) Class A ordinary shares to the new ratio of one (1) ADS representing twenty (20) Class A ordinary shares. For the Company's ADS holders, this ratio change will have the same effect as a one-for-ten reverse ADS split. prnewswire.com - 6 months ago

111, Inc. (YI) Q3 2024 Earnings Call Transcript 111, Inc. (NASDAQ:YI ) Q3 2024 Results Conference Call November 27, 2024 7:30 AM ET Company Participants Dr. Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Haihui Wang - Chief Operating Officer Conference Call Participants Jessie Lu - HSBC Robert Sassoon - Water Tower Research Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the Company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr. seekingalpha.com - 7 months ago

111, Inc. Announces Third Quarter 2024 Unaudited Financial Results Maintained Operational Profitability for the Third Consecutive Quarter Operating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoY Held Positive Operating Cash Flow for Three Consecutive Quarters SHANGHAI , Nov. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Net revenues were RMB3.6 billion (US$513.1 million), remaining relatively flat compared to the same quarter last year. prnewswire.com - 7 months ago

111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024 SHANGHAI , Nov. 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research ("WTR") on Friday, December 6, 2024 at 11:00 a.m. ET. Mr. Junling Liu, Co-Founder, Chairman, and Chief Executive Officer of 111, will discuss the Company's Q3 2024 earnings (to be reported on Wednesday, November 27, 2024), along with challenges, opportunities, and the NASDAQ share price compliance issue. prnewswire.com - 7 months ago

111 Reschedules Third Quarter 2024 Unaudited Financial Results Announcement to November 27, 2024 - Conference Call to Follow SHANGHAI , Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that its release of unaudited financial results for the third quarter ended September 30, 2024, previously scheduled for Thursday, November 28, 2024, will now occur before the U.S. market opens on Wednesday, November 27, 2024. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Wednesday, November 27, 2024 (8:30 PM Beijing Time on the same day). prnewswire.com - 8 months ago

8. Profile Summary

111, Inc. YI

COUNTRY CN

INDUSTRY Medical - Pharmaceuticals

MARKET CAP $ 64.4 M

Dividend Yield 0.00%

Description 111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Contact No.295 ZuChongZhi Road, Shanghai, 201203 https://www.111.com.cn

IPO Date Sept. 12, 2018

Employees 1238

Officers Mr. Alex Liu Finance Director Monica Mu IR Director Mr. Anfeng Guo Chief Innovation Officer Dr. Gang Yu Ph.D. Co-Founder & Executive Chairman Mr. Junling Liu Co-Founder, Acting Chief Financial Officer, Chairman & Chief Executive Officer Mr. Haihui Wang Co-Chief Operating Officer Mr. Pengcheng Zhu Co-Chief Operating Officer

Price Chart YI

111, Inc. YI

Free

Unlimited Plan

Premium Plan